New pill aims to keep narcolepsy patients awake and steady
Symptom relief
Not yet recruiting
This study tests whether a new tablet called ALKS 2680 can help adults with narcolepsy type 1 stay awake longer and have fewer sudden muscle weakness episodes (cataplexy). About 150 participants will receive either the study drug or a placebo for 12 weeks. The goal is to see if t…
Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC